Skip to main content
NCBI home page
Gut logoLink to Gut
. 1993;34(2 Suppl):S87–S90. doi: 10.1136/gut.34.2_suppl.s87

Interferon alfa-2b therapy in children with chronic hepatitis B.

E M Sokal 1, S Wirth 1, P Goyens 1, A Depreterre 1, C Cornu 1
PMCID: PMC1374019  PMID: 8314496

Abstract

Twenty nine children (mean age 8.3 years, 18 boys, 11 girls) who had biopsy proved chronic hepatitis B virus infection (HBV) with active viral replication were given a 16 week course of interferon alfa-2b treatment (9 million units (MU)/m2, thrice weekly). Fourteen children (48%) showed persistent loss of HBV-DNA 8 months after the end of treatment; 11 (38%) lost hepatitis B e antigen (HBeAg), and two (7%) hepatitis B surface antigen (HBsAg). Alanine aminotransferase activities returned to normal in 12 children. Those who responded had significantly higher initial transaminase activities than those who did not (p < 0.01) but similar serum HBV-DNA. Results were compared with the natural evolution of the disease in a group of 25 children (mean age 8.3 years) with identical initial mean serum HBV-DNA values, followed up during the same period. Two of these (8%) lost HBeAg and one (4%) HBsAg. The 23 remaining control subjects had no decrease in serum HBV-DNA or in transaminase activities compared with values 1 year earlier. It is concluded that treatment with interferon alfa-2b in children may lead to inhibition of HBV replication similar to that described in adults, and may thus shorten disease evolution. Further studies are necessary to establish the best protocols and to identify those patients who are the most likely to respond to treatment.

Full text

PDF
S87

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brook M. G., Karayiannis P., Thomas H. C. Which patients with chronic hepatitis B virus infection will respond to alpha-interferon therapy? A statistical analysis of predictive factors. Hepatology. 1989 Nov;10(5):761–763. doi: 10.1002/hep.1840100502. [DOI] [PubMed] [Google Scholar]
  2. Chang M. H., Chen P. J., Chen J. Y., Lai M. Y., Hsu H. C., Lian D. C., Liu Y. G., Chen D. S. Hepatitis B virus integration in hepatitis B virus-related hepatocellular carcinoma in childhood. Hepatology. 1991 Feb;13(2):316–320. [PubMed] [Google Scholar]
  3. Coppens J. P., Cornu C., Lens E., Lamy M., Geubel A. P. Prospective trial of recombinant leucocyte interferon in chronic hepatitis B: a long-term follow-up study. J Hepatol. 1990;11 (Suppl 1):S126–S128. doi: 10.1016/0168-8278(90)90178-t. [DOI] [PubMed] [Google Scholar]
  4. Crivellaro C., Cadrobbi P., Perilongo G., Rossetti F., Pontisso P., Bortolotti F. Chronic type B hepatitis and primary hepatocellular carcinoma in children. Eur J Pediatr. 1991 Jul;150(9):685–685. doi: 10.1007/BF02072636. [DOI] [PubMed] [Google Scholar]
  5. Fevery J., Elewaut A., Michielsen P., Nevens F., Van Eyken P., Adler M., Desmet V. Efficacy of interferon alfa-2b with or without prednisone withdrawal in the treatment of chronic viral hepatitis B. A prospective double-blind Belgian-Dutch study. J Hepatol. 1990;11 (Suppl 1):S108–S112. doi: 10.1016/0168-8278(90)90174-p. [DOI] [PubMed] [Google Scholar]
  6. Hsu H. C., Wu M. Z., Chang M. H., Su I. J., Chen D. S. Childhood hepatocellular carcinoma develops exclusively in hepatitis B surface antigen carriers in three decades in Taiwan. Report of 51 cases strongly associated with rapid development of liver cirrhosis. J Hepatol. 1987 Dec;5(3):260–267. doi: 10.1016/s0168-8278(87)80030-2. [DOI] [PubMed] [Google Scholar]
  7. Ko Y. C., Li S. C., Yen Y. Y., Yeh S. M., Hsieh C. C. Horizontal transmission of hepatitis B virus from siblings and intramuscular injection among preschool children in a familial cohort. Am J Epidemiol. 1991 May 15;133(10):1015–1023. doi: 10.1093/oxfordjournals.aje.a115810. [DOI] [PubMed] [Google Scholar]
  8. Korenman J., Baker B., Waggoner J., Everhart J. E., Di Bisceglie A. M., Hoofnagle J. H. Long-term remission of chronic hepatitis B after alpha-interferon therapy. Ann Intern Med. 1991 Apr 15;114(8):629–634. doi: 10.7326/0003-4819-114-8-629. [DOI] [PubMed] [Google Scholar]
  9. Lee P. I., Chang M. H., Lee C. Y., Hsu H. Y., Chen J. S., Chen P. J., Chen D. S. Changes of serum hepatitis B virus DNA and aminotransferase levels during the course of chronic hepatitis B virus infection in children. Hepatology. 1990 Oct;12(4 Pt 1):657–660. doi: 10.1002/hep.1840120406. [DOI] [PubMed] [Google Scholar]
  10. Leichtner A. M., Leclair J., Goldmann D. A., Schumacher R. T., Gewolb I. H., Katz A. J. Horizontal nonparenteral spread of hepatitis B among children. Ann Intern Med. 1981 Mar;94(3):346–349. doi: 10.7326/0003-4819-94-3-346. [DOI] [PubMed] [Google Scholar]
  11. Lok A. S., Lai C. L., Wu P. C., Leung E. K., Lam T. S. Spontaneous hepatitis B e antigen to antibody seroconversion and reversion in Chinese patients with chronic hepatitis B virus infection. Gastroenterology. 1987 Jun;92(6):1839–1843. doi: 10.1016/0016-5085(87)90613-5. [DOI] [PubMed] [Google Scholar]
  12. Perrillo R. P., Schiff E. R., Davis G. L., Bodenheimer H. C., Jr, Lindsay K., Payne J., Dienstag J. L., O'Brien C., Tamburro C., Jacobson I. M. A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group. N Engl J Med. 1990 Aug 2;323(5):295–301. doi: 10.1056/NEJM199008023230503. [DOI] [PubMed] [Google Scholar]
  13. Rizzetto M., Recchia S., Salizzoni M. Liver transplantation in carriers of the HBsAg. J Hepatol. 1991 Jul;13(1):5–7. doi: 10.1016/0168-8278(91)90855-6. [DOI] [PubMed] [Google Scholar]
  14. Ruiz Moreno M., Jimenez J., Porres J. C., Bartolomé J., Moreno A., Carreño V. A controlled trial of recombinant interferon-alpha in Caucasian children with chronic hepatitis B. Digestion. 1990;45(1):26–33. doi: 10.1159/000200221. [DOI] [PubMed] [Google Scholar]
  15. Ruiz-Moreno M., Rua M. J., Molina J., Moraleda G., Moreno A., García-Aguado J., Carreño V. Prospective, randomized controlled trial of interferon-alpha in children with chronic hepatitis B. Hepatology. 1991 Jun;13(6):1035–1039. [PubMed] [Google Scholar]
  16. Todo S., Demetris A. J., Van Thiel D., Teperman L., Fung J. J., Starzl T. E. Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology. 1991 Apr;13(4):619–626. [PMC free article] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES